NOVA ready to bounce back on lower support ?
Updated
NOVA announced today that they've just earned Psilocybin Orphan Drug Designation in Europe that once approved would give them ten years of market exclusivity. Positive news are accumulating for this small biopharma over the last 3 months and at some point investors will start accumulating again as it sits on a well supported floor at .08
I keep adding slowly at the current range and would expect a quick run to .14-.15 as soon as some volume comes back (do you DD and own analysis!)
I keep adding slowly at the current range and would expect a quick run to .14-.15 as soon as some volume comes back (do you DD and own analysis!)
Note
Bouncing away from its support level on increasing volume so expecting it to test its first resistance at .14 this week now.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.